Show simple item record

dc.contributor.authorAlsayegh, Faisal
dc.contributor.authorKamaliddin, Hassan
dc.contributor.authorSheshah, Eman
dc.contributor.authorBukhamseen, Nasir
dc.contributor.authorAlkhuwaitir, Tarig
dc.contributor.authorElhoufi, Ashraf
dc.date2022-08-11T08:08:08.000
dc.date.accessioned2022-08-23T15:43:31Z
dc.date.available2022-08-23T15:43:31Z
dc.date.issued2012-06-08
dc.date.submitted2014-12-12
dc.identifier.citationMed Princ Pract. 2012;21(6):522-8. doi: 10.1159/000339081. Epub 2012 Jun 8. <a href="http://dx.doi.org/10.1159/000339081">Link to article on publisher's site</a>
dc.identifier.issn1011-7571 (Linking)
dc.identifier.doi10.1159/000339081
dc.identifier.pmid22688685
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27115
dc.description.abstractOBJECTIVES: To assess the prevalence of venous thromboembolism (VTE) risk in acutely ill surgical and medical patients in selected acute care centres in the Arabian Gulf States, and to determine the proportion of at-risk patients who received effective prophylaxis in accordance with 2004 American College of Chest Physicians (ACCP) guidelines. MATERIALS AND METHODS: Eight hospitals from 3 countries (Kuwait, Kingdom of Saudi Arabia, and United Arab Emirates) contributed to the global ENDORSE (Epidemiological International Day for the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting) study. Medical records were reviewed for all the in-patients aged > / = 40 years admitted to medical wards, and in patients aged > / = 18 admitted to surgical wards. The VTE risk and recommended prophylaxis were assessed according to the 2004 ACCP guidelines. RESULTS: Of 1,291 evaluable patients, 801 were considered at risk of VTE; 391 (48.8%) surgical patients and 410 (51.2%) medical patients. Of the 801 patients, 322 (40.2%) received ACCP-recommended VTE prophylaxis; 159 (40.7%) of surgical patients and 163 (39.8%) of medical patients. CONCLUSIONS: The data showed that VTE prophylaxis was underutilized in high-risk hospitalized patients. We recommend that active measures should be implemented in acute care centres in these Arabian Gulf countries to ensure identification of patients at risk of VTE and institute the appropriate prophylaxis.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=22688685&dopt=Abstract">Link to Article in PubMed</a>
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/
dc.subjectAcute Disease
dc.subjectAnti-Inflammatory Agents, Non-Steroidal
dc.subjectAnticoagulants
dc.subjectArabs
dc.subjectAspirin
dc.subjectCritical Care
dc.subjectFemale
dc.subjectHumans
dc.subjectKuwait
dc.subjectLength of Stay
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPlatelet Aggregation Inhibitors
dc.subjectPrevalence
dc.subjectRisk
dc.subjectSaudi Arabia
dc.subjectUnited Arab Emirates
dc.subjectVenous Thromboembolism
dc.subjectArabian Gulf
dc.subjectThromboembolism
dc.subjectProphylaxis
dc.subjectENDORSE study
dc.subjectKuwait
dc.subjectSaudi Arabia
dc.subjectUnited Arab Emirates
dc.subjectCardiovascular Diseases
dc.subjectClinical Epidemiology
dc.subjectEpidemiology
dc.subjectHealth Services Research
dc.subjectSurvival Analysis
dc.subjectVital and Health Statistics
dc.titleAssessment of venous thromboembolism risk and adequacy of prophylaxis in selected acute care medical centres in Arabian Gulf States: results from the ENDORSE study
dc.typeJournal Article
dc.source.journaltitleMedical principles and practice : international journal of the Kuwait University, Health Science Centre
dc.source.volume21
dc.source.issue6
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1015&amp;context=cor_endorse&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cor_endorse/16
dc.identifier.contextkey6456544
refterms.dateFOA2022-08-23T15:43:32Z
html.description.abstract<p>OBJECTIVES: To assess the prevalence of venous thromboembolism (VTE) risk in acutely ill surgical and medical patients in selected acute care centres in the Arabian Gulf States, and to determine the proportion of at-risk patients who received effective prophylaxis in accordance with 2004 American College of Chest Physicians (ACCP) guidelines.</p> <p>MATERIALS AND METHODS: Eight hospitals from 3 countries (Kuwait, Kingdom of Saudi Arabia, and United Arab Emirates) contributed to the global ENDORSE (Epidemiological International Day for the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting) study. Medical records were reviewed for all the in-patients aged > / = 40 years admitted to medical wards, and in patients aged > / = 18 admitted to surgical wards. The VTE risk and recommended prophylaxis were assessed according to the 2004 ACCP guidelines.</p> <p>RESULTS: Of 1,291 evaluable patients, 801 were considered at risk of VTE; 391 (48.8%) surgical patients and 410 (51.2%) medical patients. Of the 801 patients, 322 (40.2%) received ACCP-recommended VTE prophylaxis; 159 (40.7%) of surgical patients and 163 (39.8%) of medical patients.</p> <p>CONCLUSIONS: The data showed that VTE prophylaxis was underutilized in high-risk hospitalized patients. We recommend that active measures should be implemented in acute care centres in these Arabian Gulf countries to ensure identification of patients at risk of VTE and institute the appropriate prophylaxis.</p>
dc.identifier.submissionpathcor_endorse/16
dc.contributor.departmentCenter for Outcomes Research
dc.source.pages522-8


Files in this item

Thumbnail
Name:
10.1159_000339081.pdf
Size:
181.5Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc/3.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc/3.0/